
|Videos|August 1, 2020
Diabetic retinopathy progression in anti-VEGF versus FA implant (ASRS 2020)
Author(s)Alex Delaney-Gesing
Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.
Advertisement
Caesar Luo, MD, speaks with Modern Retina®/Ophthalmology Times®' Sheryl Stevenson on the take-away points from his presentation on diabetic retinopathy progression in anti-VEGF versus FA implant during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting, and how the topics from his talk may be applied day to day in retinal practice.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
New optoretinography technique allows direct measurement of rod function in vivo
2
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
3
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
4
Glaucoma innovation: Eight themes to watch in 2026
5












































